Polyneuron

Polyneuron Pharmaceuticals is a biopharmaceutical company primarily focused on developing new therapies for autoimmune diseases. The company's proprietary technology platform, Antibody-Catch, is designed to selectively inactivate disease-causing antibodies without compromising the integrity of the immune system.